The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001110792.2(MECP2):c.686C>T (p.Pro229Leu)

CA10581615

236302 (ClinVar)

Gene: MECP2
Condition: Rett syndrome
Inheritance Mode: X-linked inheritance
UUID: f2c5bce1-28a5-423f-911e-2ae5970fcbb4
Approved on: 2024-10-30
Published on: 2024-11-29

HGVS expressions

NM_001110792.2:c.686C>T
NM_001110792.2(MECP2):c.686C>T (p.Pro229Leu)
NC_000023.11:g.154031178G>A
CM000685.2:g.154031178G>A
NC_000023.10:g.153296629G>A
CM000685.1:g.153296629G>A
NC_000023.9:g.152949823G>A
NG_007107.2:g.110950C>T
NG_007107.3:g.110926C>T
ENST00000303391.11:c.650C>T
ENST00000453960.7:c.686C>T
ENST00000637917.1:c.65+218C>T
ENST00000303391.10:c.650C>T
ENST00000407218.5:c.*22C>T
ENST00000453960.6:c.686C>T
ENST00000619732.4:c.650C>T
ENST00000622433.4:c.638C>T
ENST00000628176.2:c.*22C>T
NM_001110792.1:c.686C>T
NM_001316337.1:c.371C>T
NM_004992.3:c.650C>T
NM_001316337.2:c.371C>T
NM_001369391.2:c.371C>T
NM_001369392.2:c.371C>T
NM_001369393.2:c.371C>T
NM_001369394.1:c.371C>T
NM_001369394.2:c.371C>T
NM_001386137.1:c.-20C>T
NM_001386138.1:c.-20C>T
NM_001386139.1:c.-20C>T
NM_004992.4:c.650C>T
More

Likely Pathogenic

Met criteria codes 3
PS2 PS4_Moderate PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MECP2 Version 3.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Pro217Leu variant in MECP2 (NM_004992.3) has been reported as a de novo occurrence (biological parentage both confirmed and unconfirmed) in 2 individuals with neurodevelopmental disorders (PMID: 27824329, LabCorp) (PS2). The p.Pro217Leu variant has been observed in individuals with neurodevelopmental disorders (PMID: 27824329, LabCorp, Invitae internal database) (PS4_moderate). The p.Pro217Leu in MECP2 is absent from gnomAD (PM2_supporting). In summary, the p.Pro217Leu variant in MECP2 is classified as likely pathogenic for Rett syndrome based on the ACMG/AMP criteria (PS2, PS4_moderate, PM2_supporting).
Met criteria codes
PS2
The p.Pro217Leu variant in MECP2 (NM_004992.3) has been reported as a de novo occurrence (biological parentage both confirmed and unconfirmed) in 2 individuals with neurodevelopmental disorders (PMID: 27824329, LabCorp)
PS4_Moderate
The p.Pro217Leu variant has been observed in individuals with neurodevelopmental disorders (PMID: 27824329, LabCorp, Invitae internal database) (PS4_moderate).
PM2_Supporting
The p.Pro217Leu in MECP2 (NM_004992.4) is absent from gnomAD.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.